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Abstract
Calcium (Ca2+) channels are voltage-gated ion channels present in the membrane of most excitable cells. The
nomenclature for Ca2+channels was proposed by [110] and approved by the NC-IUPHAR Subcommittee on
Ca2+ channels [60]. Ca2+ channels form hetero-oligomeric complexes. The α1 subunit is pore-forming and
provides the binding site(s) for practically all agonists and antagonists. The 10 cloned α1-subunits can be
grouped into three families: (1) the high-voltage activated dihydropyridine-sensitive (L-type, CaV1.x) channels;
(2) the high-voltage activated dihydropyridine-insensitive (CaV2.x) channels and (3) the low-voltage-activated
(T-type, CaV3.x) channels. Each α1 subunit has four homologous repeats (IIV), each repeat having six
transmembrane domains and a pore-forming region between transmembrane domains S5 and S6. Gating is
thought to be associated with the membrane-spanning S4 segment, which contains highly conserved positive
charges. Many of the α1-subunit genes give rise to alternatively spliced products. At least for high-voltage
activated channels, it is likely that native channels comprise co-assemblies of α1, β and α2δ subunits. The γ
subunits have not been proven to associate with channels other than the α1s skeletal muscle Cav1.1 channel.
The α2δ1 and α2δ2 subunits bind gabapentin and pregabalin.
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